Universal Off The Shelf Car

Media Summary: In this interview, Dietmar Berger, MD, PhD, of Atara Biotherapeutics, San Francisco, CA, discusses the current limitations of Speaker: Meisam Naeimi, DVM, PhD In this Webinar, You Will Learn: The importance of John Maher, BA, MBBCh, BAO, MRCPI, MRCP, MSc, FRCPath, King's College London, London, UK, talks on the potential of ...

Universal Off The Shelf Car - Detailed Analysis & Overview

In this interview, Dietmar Berger, MD, PhD, of Atara Biotherapeutics, San Francisco, CA, discusses the current limitations of Speaker: Meisam Naeimi, DVM, PhD In this Webinar, You Will Learn: The importance of John Maher, BA, MBBCh, BAO, MRCPI, MRCP, MSc, FRCPath, King's College London, London, UK, talks on the potential of ... Jae Park, MD, a hematologist oncologist at Memorial Sloan Kettering Cancer Center, discusses the benefits of Stephan Grupp, MD, PhD, Children's Hospital of Philadelphia, Philadelphia, PA, discusses the potential of having " Adam Sperling, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, reflects on allogeneic and

Catherine Bollard, MBChB, MD, FRACP, FRCPA, Children's National Health System, Washington, DC, outlines studies exploring ...

Photo Gallery

Off-the-shelf CAR T-cell therapy

Universal “off-the-shelf” CAR T-cells from iPSCs

Cell Therapy: Off-the-Shelf CAR γδT Cells Generated Using CRISPR/AAV

Allogeneic CAR-T Therapy: Understanding This New Approach in Myeloma Immunotherapy

Generating off-the-shelf CAR-Ts with iPSCs

Dr. Park on the Benefits of Off-the-Shelf CAR T-Cell Therapy in ALL

"Off-the-shelf" CAR-T: future prospects

Challenges associated with the use of off-the-shelf CAR-T products in multiple myeloma

Universal “off-the-shelf” CAR T-cells from iPSCs

Off-the-shelf CAR-T for T-cell malignancies: UCART3

Clinical Trial of universal off the shelf Base Edited CD7-CAR-T cells #Code: 1117

Building "Off-the-Shelf" CAR T-cells - Sidharth Raghavan

View Detailed Profile

Off-the-shelf CAR T-cell therapy

Off-the-shelf CAR T-cell therapy

In this interview, Dietmar Berger, MD, PhD, of Atara Biotherapeutics, San Francisco, CA, discusses the current limitations of

Universal “off-the-shelf” CAR T-cells from iPSCs

Universal “off-the-shelf” CAR T-cells from iPSCs

Current

Cell Therapy: Off-the-Shelf CAR γδT Cells Generated Using CRISPR/AAV

Cell Therapy: Off-the-Shelf CAR γδT Cells Generated Using CRISPR/AAV

Speaker: Meisam Naeimi, DVM, PhD In this Webinar, You Will Learn: The importance of

Allogeneic CAR-T Therapy: Understanding This New Approach in Myeloma Immunotherapy

Allogeneic CAR-T Therapy: Understanding This New Approach in Myeloma Immunotherapy

Allogeneic

Generating off-the-shelf CAR-Ts with iPSCs

Generating off-the-shelf CAR-Ts with iPSCs

John Maher, BA, MBBCh, BAO, MRCPI, MRCP, MSc, FRCPath, King's College London, London, UK, talks on the potential of ...

Dr. Park on the Benefits of Off-the-Shelf CAR T-Cell Therapy in ALL

Dr. Park on the Benefits of Off-the-Shelf CAR T-Cell Therapy in ALL

Jae Park, MD, a hematologist oncologist at Memorial Sloan Kettering Cancer Center, discusses the benefits of

"Off-the-shelf" CAR-T: future prospects

"Off-the-shelf" CAR-T: future prospects

Stephan Grupp, MD, PhD, Children's Hospital of Philadelphia, Philadelphia, PA, discusses the potential of having "

Challenges associated with the use of off-the-shelf CAR-T products in multiple myeloma

Challenges associated with the use of off-the-shelf CAR-T products in multiple myeloma

Adam Sperling, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, reflects on allogeneic and

Universal “off-the-shelf” CAR T-cells from iPSCs

Universal “off-the-shelf” CAR T-cells from iPSCs

Current

Off-the-shelf CAR-T for T-cell malignancies: UCART3

Off-the-shelf CAR-T for T-cell malignancies: UCART3

While

Clinical Trial of universal off the shelf Base Edited CD7-CAR-T cells #Code: 1117

Clinical Trial of universal off the shelf Base Edited CD7-CAR-T cells #Code: 1117

Gist: Here the researchers prepared a

Building "Off-the-Shelf" CAR T-cells - Sidharth Raghavan

Building "Off-the-Shelf" CAR T-cells - Sidharth Raghavan

Sidharth presents on Building "

Advances in off-the-shelf CAR T-cells

Advances in off-the-shelf CAR T-cells

Catherine Bollard, MBChB, MD, FRACP, FRCPA, Children's National Health System, Washington, DC, outlines studies exploring ...